Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/688117 stock hub

SHA/688117 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/688117is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.8B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/688117

In the news

Latest news · SHA/688117

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.4

P25 17.1P50 24.2P75 37.8

Trailing P/E32.8

P25 23.5P50 41.3P75 83.2

ROE16.9

P25 -0.9P50 4.1P75 8.8

ROIC16.3

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/688117 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

CNY

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,450
Enterprise value	CNY 6.1B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000051M8
Last refreshed	2026-05-10
Market cap	CNY 5.8B
Price	CNY 36.75
Price currency	CNY
Rev Per Employee	580,306.87x
Sector	Healthcare
Sic	2834
Symbol	sha/688117
Website	https://www.snbiopharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.06%
EV Earnings	34.22x
EV/EBIT	23.31x
EV/EBITDA	18.81x
EV/FCF	396.82x
EV/Sales	7.57x
FCF yield	0.26%
Forward P/E	21.37x
P/B ratio	5.14x
P/E ratio	32.81x
P/S ratio	7.22x
PE Ratio3 Y	44.75x
PE Ratio5 Y	44.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.45%
EBITDA Margin	40.23%
FCF margin	1.91%
Gross margin	58.69%
Gross Profit	CNY 470.3M
Gross Profit Growth	55.68%
Gross Profit Growth Q	41.42%
Gross Profit Growth3 Y	23.21%
Gross Profit Growth5 Y	8.44%
Net Income	CNY 177.2M
Net Income Growth	119.62%
Net Income Growth Q	40.84%
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Net Income Growth3 Y	40.25%
Net Income Growth5 Y	23.55%
Pretax Margin	26.15%
Profit Margin	22.11%
Profit Per Employee	CNY 128,289
Profitable Years	9
ROA	8.85
Roa5y	4.84
ROCE	16.65
ROE	16.95
Roe5y	9.56
ROIC	16.32
Roic5y	11.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	58.65%
Cagr3y	33.29%
EPS Growth	118.2
EPS Growth Q	40
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	39.15
EPS Growth5 Y	16.62
FCF Growth5 Y	-0.25%
OCF Growth	571.41%
OCF Growth3 Y	21%
OCF Growth5 Y	13.64%
Revenue Growth	49.42x
Revenue Growth Q	32.52x
Revenue Growth Quarters	5x
Revenue Growth Years	8x
Revenue Growth3 Y	26.44x
Revenue Growth5 Y	14.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.44
Assets	CNY 2B
Cash	CNY 297.7M
Current Assets	CNY 948.1M
Current Liabilities	CNY 446.8M
Debt	CNY 576.4M
Debt EBITDA	CNY 1.79
Debt Equity	CNY 0.51
Debt FCF	CNY 37.73
Equity	CNY 1.1B
Liabilities	CNY 883.8M
Long Term Assets	CNY 1.1B
Long Term Liabilities	CNY 437M
Net Cash	CNY -278.7M
Net Cash By Market Cap	CNY -4.82
Net Debt EBITDA	CNY 0.86
Net Debt Equity	CNY 0.25
Net Debt FCF	CNY 18.24
Tangible Book Value	CNY 1B
Tangible Book Value Per Share	CNY 6.61
WACC	7.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.12
Inventory Turnover	1.01
Net Working Capital	CNY 463.9M
Quick ratio	1.17
Working Capital	CNY 501.3M
Working Capital Turnover	CNY 2.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.65%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	CNY 0.06
Dividend Years	4
Dividend Yield	0.17%
Ex Div Date	2025-11-17
Last Dividend	CNY 0.03
Payout Frequency	Annual
Payout Ratio	21.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	58.6%
200-day SMA	39.31
3Y total return	136.86%
50-day SMA	36.68
50-day SMA vs 200-day SMA	50under200
All Time High	47.97
All Time High Change	-23.39%
All Time High Date	2025-08-20
All Time Low	10.54
All Time Low Change	248.64%
All Time Low Date	2022-10-10
ATR	1.37
Beta	0.68
Beta1y	0.44
Beta2y	0.33
Ch YTD	-2.75
High	37.3
High52	47.97
High52 Date	2025-08-20
High52ch	-23.39%
Low	36.52
Low52	22.16
Low52 Date	2025-05-12
Low52ch	67.05%
Ma50ch	0.2%
Price vs 200-day SMA	-6.51%
RSI	49.09
RSI Monthly	60.89
RSI Weekly	47.8
Sharpe ratio	1.46x
Sortino ratio	2.73
Total Return	-0.48%
Tr YTD	-2.75
Tr1m	2.71%
Tr1w	-0.08%
Tr3m	-5.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 260.1M
Operating Income Growth	104.5
Operating Income Growth Q	38.8
Operating Income Growth3 Y	56.28
Operating Income Growth5 Y	34.29
Operating margin	32.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,877,242%
Net Borrowing	113,555,460
Shares Insiders	2.14%
Shares Institutions	13.67%
Shares Out	157,385,978
Shares Qo Q	-2.04%
Shares Yo Y	0.65%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 15.3M
Average Volume	3,791,095.1x
Bv Per Share	7.12
CAPEX	CNY -132.3M
Ch1m	2.71
Ch1w	-0.08
Ch1y	58.02
Ch3m	-5.38
Ch3y	132.8
Ch6m	-5.5
Change	-1.29%
Change From Open	-1.47
Close	37.23
Days Gap	0.19
Depreciation Amortization	62,272,952
Dollar Volume	95,248,135.5
Earnings Date	2026-04-24
EBIT	CNY 260.1M
EBITDA	CNY 322.4M
EPS	CNY 1.12
F Score	6
FCF	CNY 15.3M
FCF EV Yield	0.25x
FCF Per Share	CNY 0.1
Financing CF	140,456,409
Fiscal Year End	December
Founded	2,001
Graham Number	13.39418
Graham Upside	-63.55
Income Tax	CNY 32.4M
Investing CF	-269,400,507
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2025-06-13
Last Split Type	Forward
Lynch Fair Value	CNY 26.38
Lynch Upside	-28.23
Ma150	38.84
Ma150ch	-5.37%
Ma20	37.07
Ma20ch	-0.85%
Net CF	17,258,271
Next Earnings Date	2026-07-31
Open	37.3
P FCF Ratio	378.6
P OCF Ratio	39.2
Payment Date	2025-11-17
Position In Range	29.49
Ppne	772,223,194
Price Date	2026-05-08
Price EBITDA	CNY 17.94
Ptbv Ratio	5.54
Relative Volume	0.68x
Revenue	801,403,788x
Tax By Revenue	4.05x
Tax Rate	15.47%
Tr6m	-5.43%
Volume	2,591,786

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/688117 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$0.06 annual per share

Payout ratio

+21.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-0.5%

Next ex-dividend date: 2025-11-17

Performance

SHA/688117 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/688117?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.7%

Share of float held by funds and institutions

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.6%

Negative means the company is buying back shares.

Technical

SHA/688117 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.1

Neutral momentum band

Price vs 200-day MA

-6.5%

50/200-day relationship not available

Beta (5Y)

0.68

Less volatile than the market

Sharpe ratio

1.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/688117

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688117 stock rating?

sha/688117 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688117 analysis?

The full report lives at /stocks/sha/688117/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688117?

The latest report frames sha/688117 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688117 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.